NEXT PHARMA SOURCING S.A.S — Heparin Importer Profile
Pharmaceutical Importer · #17 buyer for Heparin · $2.4M import value · 48 shipments · COLOMBIA · DGFT Verified
NEXT PHARMA SOURCING S.A.S is the #17 importer of Heparin from India with $2.4M in import value and 48 verified shipments. NEXT PHARMA SOURCING S.A.S holds a 0.5% market share in Heparin imports based in COLOMBIA. The company sources from 1 verified supplier across 17 formulations shipped to 1 country. Overall, NEXT PHARMA SOURCING S.A.S imports 3 pharmaceutical products worth $3.1M across 3 therapeutic categories.
NEXT PHARMA SOURCING S.A.S — Heparin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Heparin to NEXT PHARMA SOURCING S.A.S?
Verified from 48 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $2.4M | 48 | 100.0% |
NEXT PHARMA SOURCING S.A.S sources Heparin from 1 verified Indian supplier based on 48 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
How Does NEXT PHARMA SOURCING S.A.S Compare to Nearest Heparin Importers?
Buyers ranked immediately above and below #17 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 16 | ASCEND LABORATORIES SPA | CHILE | $2.1M | 42 | $50.0K |
| 11 | EVERSANA LIFE SCIENCE SERVICES LLC | UNITED STATES | $1.9M | 38 | $50.0K |
| 17 | NEXT PHARMA SOURCING S.A.S ★ | COLOMBIA | $1.9M | 38 | $50.0K |
| 9 | E U PHARMACEUTICALS CO.,LTD | THAILAND | $1.4M | 28 | $50.0K |
| 3 | NUEVOS ETICOS NEOETHICALS, S.A. | GUATEMALA | $1.1M | 22 | $50.0K |
NEXT PHARMA SOURCING S.A.S ranks #17 among 854 Heparin importers from India. Average shipment value of $50.0K compared to the market average of $80.1K. The closest competitors by value are ASCEND LABORATORIES SPA and EVERSANA LIFE SCIENCE SERVICES LLC.
Where Does NEXT PHARMA SOURCING S.A.S Import Heparin To?
Destination countries from 48 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| COLOMBIA | $2.4M | 48 | 100.0% |
NEXT PHARMA SOURCING S.A.S imports Heparin to 1 country. The primary destination is COLOMBIA receiving 100.0% of shipments worth $2.4M.
What Heparin Formulations Does NEXT PHARMA SOURCING S.A.S Import?
| Formulation | Value | Shipments |
|---|---|---|
| HEPARIN INJECTION BP,25000IU/5ML,5ML VIAL | $919.1K | 19 |
| HEPARIN INJECTION BP,25000IU/5ML,5ML VIALNOS | $291.4K | 6 |
| HEPARIN INJECTION BP, 25000IU/5ML,5ML VIAL | $150.0K | 3 |
| HEPARIN INJECTION BP25000IU/5ML5ML VIAL | $150.0K | 3 |
| HEPARIN INJECTION BP, 25000IU/5ML,5ML VIALNOS | $146.1K | 3 |
| HEPARIN SODIUM INJ 25000IU/5ML (5000IU/M | $100.0K | 2 |
| HEPARIN INJECTION 25000IU/5ML,5ML VIAL | $100.0K | 2 |
| HEPARIN INJECTION 25000IU/5ML VIAL | $50.0K | 1 |
| HEPARIN SODIUM INJ 25000IU/5ML(5000IU/ML | $50.0K | 1 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0 4ML PRE FILLED SYRINGE | $50.0K | 1 |
NEXT PHARMA SOURCING S.A.S imports 17 distinct Heparin formulations from India. The top formulation is HEPARIN INJECTION BP,25000IU/5ML,5ML VIAL with 19 shipments worth $919.1K.
Who Are the Top Buyers of Heparin from India and How Much Does NEXT PHARMA SOURCING S.A.S Import?
India exported $68.4M worth of Heparin through 4,586 shipments from 391 suppliers to 137 countries, serving 854 buyers globally. NEXT PHARMA SOURCING S.A.S imports $2.4M of this total, accounting for 0.5% of India's Heparin exports with 48 shipments from COLOMBIA. This is verified from 48 customs shipment records covering 17 distinct formulations.
What Is the Average Order Value for NEXT PHARMA SOURCING S.A.S's Heparin Imports?
NEXT PHARMA SOURCING S.A.S's average Heparin order value is $49.1K per consignment, based on 48 shipments totaling $2.4M. NEXT PHARMA SOURCING S.A.S is based in COLOMBIA and ranks #17 among all Heparin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Heparin to NEXT PHARMA SOURCING S.A.S?
NEXT PHARMA SOURCING S.A.S sources Heparin from 1 verified Indian supplier: GLAND PHARMA LIMITED ($2.4M, 100.0%). This is based on 48 customs records.
How Does NEXT PHARMA SOURCING S.A.S Compare to Other Heparin Importers?
NEXT PHARMA SOURCING S.A.S ranks #17 among 854 Heparin importers from India with a 0.5% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($19.4M), EVERSANA ($13.4M), BOSTON ONCOLOGY ARABIA ($11.2M). NEXT PHARMA SOURCING S.A.S processed 48 shipments from COLOMBIA.
About NEXT PHARMA SOURCING S.A.S
NEXT PHARMA SOURCING S.A.S imports 3 products worth $3.1M. Beyond Heparin, top products include Immunoglobulin, Azathioprine. View the complete NEXT PHARMA SOURCING S.A.S profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Heparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Heparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: NEXT PHARMA SOURCING S.A.S matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as NEXT PHARMA SOURCING S.A.S's capped import value divided by total capped export value for Heparin across all Indian exporters.
- 5.Verified Records: This page is backed by 48 individual customs records matching NEXT PHARMA SOURCING S.A.S importing Heparin, covering 17 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 854+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Heparin Import Data for NEXT PHARMA SOURCING S.A.S
Access order-level details, pricing data, supplier connections, and competitive analysis for NEXT PHARMA SOURCING S.A.S's Heparin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NEXT PHARMA SOURCING S.A.S
Full Company Profile →
3 products · $3.1M total trade · 3 categories
NEXT PHARMA SOURCING S.A.S × Heparin
Verified from customs records
Company Overview
Top Products by NEXT PHARMA SOURCING S.A.S
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for NEXT PHARMA SOURCING S.A.S.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Heparin. For current order-level data, contact TransData Nexus.